Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05793853 · ClinicalTrials.gov registry record
Hypoparathyroidism Natural History Study
A clinical trial of Hypoparathyroidism, sponsored by Columbia University.
- Recruiting
- Registry status
- 106
- Enrollment target
- 1
- Study location
NCT05793853 is a study of Hypoparathyroidism that is actively recruiting participants, run by Columbia University. The registered enrollment target is 106 participants, below the 189-participant average among 10 other Hypoparathyroidism trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05793853, a study of Hypoparathyroidism, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- 106 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective three-year natural history study of adults with hypoparathyroidism. The goal is to monitor patients with hypoparathyroidism to define end-organ damage in the context of the disease. The study objectives are to: 1. Build a prospective cohort of patients to study HPT-associated end-organ damage. 2. Determine end-organ physiologic consequences of HPT. 3. Elucidate determinants of HPT-associated end-organ damage. Funding Source - FDA OOPD
Conditions Studied
Study Locations (1)
New York
- Columbia University Medical Center - Harkness Pavillion - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2022-08-25 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05793853
The ClinicalTrials.gov registry entry for NCT05793853 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 189-participant average among 10 other Hypoparathyroidism trials with a reported enrollment target (44% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypoparathyroidism appearing as the primary indexed condition, and to 0 interventions.
NCT05793853 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05793853 about?
NCT05793853 is a clinical study titled "Hypoparathyroidism Natural History Study". This is a prospective three-year natural history study of adults with hypoparathyroidism. The goal is to monitor patients with hypoparathyroidism to define end-organ damage in the context of the disease. The study objectives are to: 1. Build a prospective cohort of patients to study HPT-associated...
What is the current status of trial NCT05793853?
This trial is currently recruiting. The enrollment target is 106 participants. The study started on 2022-08-25. Estimated completion is 2026-12.
What conditions does trial NCT05793853 study?
This clinical trial studies the following conditions: Hypoparathyroidism.
Who is sponsoring clinical trial NCT05793853?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05793853 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoparathyroidism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Global Pregnancy Registry to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to YORVIPATH® (Palopegteriparatide) During Pregnancy and Breastfeeding
RECRUITING
-
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
RECRUITING
-
Parathyroid Allotransplant for Treatment of Hypoparathyroidism
RECRUITING · Phase 1
-
A Registry for Participants With Chronic Hypoparathyroidism
ACTIVE NOT RECRUITING
-
Extension Study to Evaluate the Long-Term Safety and Tolerability of MBX 2109 in Patients With Hypoparathyroidism
ACTIVE NOT RECRUITING · Phase 2
-
Use of NPSP558 in the Treatment of Hypoparathyroidism
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.